SavedAdd your journal

Journals / Turkish Journal of Chemistry / 2013 / Cilt: 37 - Sayı: 6

Simple and convenient preparation of novel 6,8-disubstituted quinoline derivatives and their promising anticancer activities

Salih ÖKTEN
Osman ÇAKMAK
Ramazan ERENLER
Önem YÜCE
Şaban TEKİN
Pages
896–908
Publication Date
2013-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The anticancer activities of compounds 2, 7, 6, 12, 13, 15, and 16 against HeLa, HT29, and C6 tumor cell lines were tested, and 6,8-dibromo-1,2,3,4-tetrahydroquinoline (2) and 6,8-dimethoxyquinoline (6) showed significant anticancer activities against the tumor cell lines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A short and easy route is described for 6,8-disubstituted derivatives of quinoline and 1,2,3,4-tetrahydroquinoli- ne from 6,8-dibromoquinolines 2 and 7 by various substitution reactions.
📊
Key Findings & Data:While copper-promoted substitution of 6,8-dibromide 2 produced monomethoxides 3 and 4, a prolonged reaction time mainly afforded dimethoxide 6 instead of 5, whose aromatization with DDQ and substitution reaction of dibromide 7 with NaOMe in the presence of CuI also gave rise to dimethoxide 6.
💡
Conclusion & Impact:The anticancer activities of compounds 2, 7, 6, 12, 13, 15, and 16 against HeLa, HT29, and C6 tumor cell lines were tested, and 6,8-dibromo-1,2,3,4-tetrahydroquinoline (2) and 6,8-dimethoxyquinoline (6) showed significant anticancer activities against the tumor cell lines.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anticancer effect · bromoquinoline · cyanoquinoline

Abstract

A short and easy route is described for 6,8-disubstituted derivatives of quinoline and 1,2,3,4-tetrahydroquinoli- ne from 6,8-dibromoquinolines 2 and 7 by various substitution reactions. While copper-promoted substitution of 6,8-dibromide 2 produced monomethoxides 3 and 4, a prolonged reaction time mainly afforded dimethoxide 6 instead of 5, whose aromatization with DDQ and substitution reaction of dibromide 7 with NaOMe in the presence of CuI also gave rise to dimethoxide 6. Several 6,8-disubstituted quinolines were obtained by treatment of 6,8-dibromoquinoline (7) with n-BuLi followed by trapping with an electrophile [Si(Me)3Cl, S2(Me)2, and DMF]. Furthermore, 7 was also converted to mono and dicyano derivatives. The anticancer activities of compounds 2, 7, 6, 12, 13, 15, and 16 against HeLa, HT29, and C6 tumor cell lines were tested, and 6,8-dibromo-1,2,3,4-tetrahydroquinoline (2) and 6,8-dimethoxyquinoline (6) showed significant anticancer activities against the tumor cell lines.

Özet

A short and easy route is described for 6,8-disubstituted derivatives of quinoline and 1,2,3,4-tetrahydroquinoli- ne from 6,8-dibromoquinolines 2 and 7 by various substitution reactions. While copper-promoted substitution of 6,8-dibromide 2 produced monomethoxides 3 and 4, a prolonged reaction time mainly afforded dimethoxide 6 instead of 5, whose aromatization with DDQ and substitution reaction of dibromide 7 with NaOMe in the presence of CuI also gave rise to dimethoxide 6. Several 6,8-disubstituted quinolines were obtained by treatment of 6,8-dibromoquinoline (7) with n-BuLi followed by trapping with an electrophile [Si(Me)3Cl, S2(Me)2, and DMF]. Furthermore, 7 was also converted to mono and dicyano derivatives. The anticancer activities of compounds 2, 7, 6, 12, 13, 15, and 16 against HeLa, HT29, and C6 tumor cell lines were tested, and 6,8-dibromo-1,2,3,4-tetrahydroquinoline (2) and 6,8-dimethoxyquinoline (6) showed significant anticancer activities against the tumor cell lines.

🔖

Cite This Article

ÖKTEN, S., ÇAKMAK, O., ERENLER, R., YÜCE, Ö., TEKİN, Ş. (2013). Simple and convenient preparation of novel 6,8-disubstituted quinoline derivatives and their promising anticancer activities. Turkish Journal of Chemistry, Cilt: 37 - Sayı: 6, 896–908. https://ajindex.com/articles/184615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lindley, J. Tetrahedron 1984, 40, 1433–1456. Vlad´ımir, V.; Kouznetsov, V. V.; Vargas M´ endez, L. Y.; Carlos, C. M.; Mel´ endez G´ omez, M. Curr. Org. Chem. 2005, 9, 141–16. Company of a Chemistry Partner of Drug Discovery ”BioBloks inc.”, 2002,
  2. San Diego, CA, USA. http://www.bioblocks.com/quinolines.html.
  3. Manske, R. H. F.; Kulka, M. Org. React. 1953, 7, 59–98.
  4. Cheng, C. C.; Yan, S. J. Org. React. 1982, 28, 37–201.
  5. Bergstrom, F. W. Chem. Rev. 1944, 35, 153. Jones, G. In The Chemistry of Heterocyclic Compounds, Weissberger, A.; Taylor, E. C.; Eds.; John Wiley and Sons, Chichester, 1977.
  6. Reitsema, R. H. Chem. Rev. 1948, 43, 47. Bergstrom, F. W. Chem. Rev. 1944, 35, 156. Sahin, A.; Cakmak, O.; Demirtas, I.; Okten, S.; Tutar, A. Tetrahedron 2008, 64, 10068–10074.
  7. Heiniger, B.; Gakhar, G.; Prasain, K.; Hua, D. H.; Nguyen, T. A. Anticancer Res. 2010, 30, 3927–3932.
  8. Perchellet, E. M.; Crow, K. R.; Gakhar, G.; Nguyen, T. A.; Shi, A.; Hua, D. H.; Perchellet, J. P. Int. J. Oncol. 2010, 36, 673–688.
  9. Shi, A.; Nguyen, T. A.; Battina, S. K.; Rana, S.; Takemoto, D. J.; Chiang, P. K.; Hua, D. H. Bioorg. Med. Chem. Lett. 2008, 18, 3364–3368.
  10. Solomon, R. V.; Lee, H. Curr. Med. Chem. 2011, 18, 1488–1508.
  11. Alfonsi, M.; Arcadi, A.; Chiarini, M; Marinelli, F.; Tetrahedron Lett. 2011, 52, 5145–5148.
  12. Lejejs, J.; Bankovskii, Y.; Brovere, A.; Brusilovskii, P.; Zikmund, M. Chem. Papers 1991, 23, 657–666.
  13. Gilman, H.; Benkeser, R. A.; Gainer, Q. S.; Lindbad, A. E.; Marshall, F. I. J. Am. Chem. Soc. 1946, 68, 1577. Sahin, O. Y.; Okten, S.; Tekin, S; Cakmak, O. J Biotechnol. 2012, 161, 24. Berkenheim, A. M.; Antik, L. V. Zh. Obshch. Khim. 1941, 11, 537–540.
  14. Irving, H.; Pinnington, A. R. J. Chem. Soc. 1957, 290. Eisch, J. J. J. Org. Chem. 1962, 27, 1318. Arvanitis, A. G.; Gilligan, P. J.; Hartz, R. A. Patent: US2003/171380 A1, 2003. Merch Sharp and Dohme Corp; Coburn, C. A.; Rosenblum, S. B.; Kozlowski, J. A.; Soll, R.; Wu, H.; Hu, B.; Zhong, B. Wang, D.; Shen, C.; Sun, F. Patent:WO2012/125926 A2, 2012.